Michael P. Wachter - Concepedia

Author

Michael P. Wachter

Also Known As

M Wachter, M. P. WACHTER, M. P. Wachter, M. WACHTER, M.P. Wachter, Michael P Wachter, Michael P. Wachter, Michael Wachter, Michael Wächter

Publications

976

Citations

H-Index

Concepts

All Affiliations

Johnson & Johnson (United States)Vanderbilt University

About

Michael P. Wachter is an author at Johnson & Johnson (United States) specializing in pharmacology, natural sciences, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	425
2	Natural Sciences	14	14	454
3	Biochemistry	9	9	293
4	Engineering	3	3	76
5	Public Health	1	1	25

Michael P. Wachter

Publications

911

Citations

H-Index

Page 1

	Year	Citations
RWJ 67657, a Potent, Orally Active Inhibitor of p38 Mitogen-Activated Protein Kinase Scott Wadsworth, Druie Cavender, Scott A. Beers, Journal of Pharmacology and Experimental Therapeutics	1999	158
1,3-Diarylcycloalkanopyrazoles and diphenyl hydrazides as selective inhibitors of cyclooxygenase-2 Zhihua Sui, Jihua Guan, Michael P. Ferro, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesPharmacological Agent	2000	76
Zoapatanol and montanol, novel oxepane diterpenoids, from the Mexican plant zoapatle (Montanoa tomentosa) Seymour D. Levine, Richard E. W. Adams, Robert Chen, Journal of the American Chemical Society Novel Oxepane DiterpenoidsPetroleomicsBioorganic ChemistryNatural SciencesAltmetric Attention Score	1979	64
N-Hydroxyurea and hydroxamic acid inhibitors of cyclooxygenase and 5-lipoxygenase Peter J. Connolly, Steven K. Wetter, Kimberly N. Beers, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesMechanism Of Action	1999	42
Synthesis and structure–activity relationships of 3,5-diarylisoxazoles and 3,5-diaryl-1,2,4-oxadiazoles, novel classes of small molecule interleukin-8 (IL-8) receptor antagonists Michele A. Weidner‐Wells, Todd C. Henninger, Stephanie A. Fraga‐Spano, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesReceptor Antagonists	2004	38
Syntheses and biological evaluation of two new naproxen analogs Kyung Woon Jung, Kim D. Janda, Pauline J. Sanfilippo, Bioorganic & Medicinal Chemistry Letters PharmacologyNew Naproxen AnalogsBioorganic ChemistryNatural Product Synthesis	1996	36
Synthesis and antifertility activity of zoapatanol analogs Ramesh M. Kanojia, Eva Chin, Carol Smith, Journal of Medicinal Chemistry Orf 13811Medicinal ChemistryPharmaceutical ScienceZoapatanol AnalogsPharmacological Study	1985	35
N-(5-substituted) thiophene-2-alkylsulfonamides as potent inhibitors of 5-lipoxygenase Scott A. Beers, Elizabeth A. Malloy, Wei Wu, Bioorganic & Medicinal Chemistry Medicinal ChemistryBiochemistryNatural SciencesMedicinePotent Inhibitors	1997	34
Isolation and structural elucidation of zoapatanol and montanol, novel oxepane diterpenoids from the Mexican plant zoapatle (Montanoa tomentosa) Ramesh M. Kanojia, Michael P. Wachter, Seymour D. Levine, The Journal of Organic Chemistry Novel Oxepane DiterpenoidsChemical EngineeringPetroleomicsBioorganic ChemistryEngineering	1982	34
A simple regioselective synthesis of ethyl 1,5‐diarylpyrazole‐3‐carboxylates William V. Murray, Michael P. Wachter Journal of Heterocyclic Chemistry EngineeringSimple Regioselective SynthesisArylphenylhydrazine HydrochloridesOrganic ChemistryNew Procedures	1989	32

Page 1